Barrington Research Maintains Outperform on Concentrix, Maintains $84 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Vincent Colicchio has reiterated an 'Outperform' rating for Concentrix (NASDAQ:CNXC) with a maintained price target of $84.
September 23, 2024 | 2:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has reaffirmed its 'Outperform' rating for Concentrix, maintaining a price target of $84. This suggests confidence in the company's performance and potential for stock appreciation.
The reaffirmation of an 'Outperform' rating and a stable price target of $84 by Barrington Research indicates a positive outlook on Concentrix's stock. This can lead to increased investor confidence and potential stock price appreciation in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100